Tetra-n-butylammonium dihydrogen trifluoride, 90.0%, 5g

Objectif IOS corrigé à l'infini par immersion dans l'huile E-plan EPLi S100x/1.25. Distance de travail 0,36 mm

4-(3-(Hexahydrocyclopenta[c]pyrrol-2(1H)-yl)propoxy)benzamide, 98%, 1mg

2-Bromo-N-ethyl-N-methyl-acetamide, 95.0%, 1g

Methyl (3,5-Dimethoxyphenyl)acetate>98.0%(GC)5g

3-hydroxy-4,4-dimethyl-1-(thiophen-3-yl)pent-2-en-1-one, 98%, 500mg

3-(1-Naphthyl)propionic Acid, 98.0%, 10g

(S)-4-(tert-Butyl)-2-(6-phenylpyridin-2-yl)-4,5-dihydrooxazole, 97%, 100mg

(R)-1-((Benzyloxy)carbonyl)-4,4-difluoropyrrolidine-2-carboxylic acid, 98%, 250mg

4'-methoxy-3-(2-methylphenyl)propiophenone, 97.0%, 1g

N-(p-Toluenesulfonyl)-ethylene diamine, 90.0%, 25g

L-Alanine, N-[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)ethyl]-3-[[(9H-fluoren-9-ylmethoxy)carbonyl]amino]-, 95%, 5g

Aldéhyde laurique, min.98%, pour la synthèse, 50 ml, emballage en verre